Bottom line
IXJ vs PINK: the short answer
IXJ (iShares Global Healthcare ETF) and PINK (Simplify Health Care ETF) share a meaningful slice of their top holdings — about 41% by weight.
But IXJ is far broader, holding 124 positions to 54 for PINK, so beyond the top names it adds exposure PINK doesn't have.
IXJ is cheaper at 0.38% vs 0.51% — a difference of $13 a year per $10,000 invested.
Over one year, PINK returned +24.1% vs +14.9% for IXJ.
Updated Nov 19, 2026
IXJ vs PINK side by side
| IXJ | PINK | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | iShares | Simplify Exchange Traded |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.38% | 0.51% |
| Annual cost per $10k | $38 | $51 |
| 10-yr cost on $10k (prospectus) | $480 | $641 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +14.9% | +24.1% |
| 5-yr return (annualized) | +6.4% | — |
| 10-yr return (annualized) | +8.2% | — |
| Best quarter | +13.6% | +15.6% |
| Worst quarter | −11.8% | −9.5% |
| Net assets (fund) | $3.8B | $358.6M |
| Number of holdings | 124 | 54 |
| Portfolio turnover | 2% | 171% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IXJ | PINK | Difference |
|---|---|---|---|
| 2025 | +14.9% | +24.1% | −9.2% |
| 2024 | +0.6% | +8.9% | −8.3% |
| 2023 | +3.5% | +3.8% | −0.3% |
| 2022 | −4.7% | −4.3% | −0.4% |
Source: Fund prospectus bar charts
Holdings overlap
12 of IXJ's top 25 holdings also appear in PINK's top 25.
| Holding | IXJ | PINK |
|---|---|---|
| Eli Lilly And Company | 10.93% | 5.91% |
| Johnson & Johnson | 7.04% | 5.45% |
| Abbvie Inc. | 5.12% | 4.52% |
| Unitedhealth Group Incorporated | 4.40% | 5.76% |
| Astrazeneca Plc | 3.76% | 1.81% |
| Amgen Inc. | 2.54% | 2.12% |
| Thermo Fisher Scientific Incorporated | 2.42% | 3.23% |
| Gilead Sciences, Inc. | 2.04% | 2.87% |
| Cvs Health Corporation | 1.71% | 2.01% |
| Vertex Pharmaceuticals Incorporated | 1.64% | 1.45% |
| Danaher Corporation | 1.56% | 2.28% |
| Elevance Health, Inc. | 1.09% | 2.73% |
Source: SEC Form N-PORT
IXJ top 10
- Eli Lilly And Company — 10.93%
- Johnson & Johnson — 7.04%
- Abbvie Inc. — 5.12%
- Unitedhealth Group Incorporated — 4.40%
- Merck & Co., Inc. — 4.12%
- Astrazeneca Plc — 3.76%
- Roche Holding AG — 3.75%
- Novartis AG — 3.71%
- Amgen Inc. — 2.54%
- Thermo Fisher Scientific Incorporated — 2.42%
PINK top 10
- Purecycle Technologies Inc — 6.89%
- United Therapeutics Corp — 6.86%
- Novo Nordisk A/s — 6.75%
- Eli Lilly & Company — 5.91%
- Unitedhealth Group Inc — 5.76%
- Warby Parker Inc — 5.46%
- Johnson & Johnson — 5.45%
- Jazz Pharmaceuticals Plc — 4.61%
- Abbvie Inc — 4.52%
- Biohaven Ltd — 4.32%
FAQ
What is the difference between IXJ and PINK?
Which is cheaper, IXJ or PINK?
Should I own both IXJ and PINK?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.